Enhanced sensitivity to sorafenib by inhibition of Akt1 expression in human renal cell carcinoma ACHN cells both in vitro and in vivo

被引:0
|
作者
Hiromoto Tei
Hideaki Miyake
Masato Fujisawa
机构
[1] Kobe University Graduate School of Medicine,Division of Urology
来源
Human Cell | 2015年 / 28卷
关键词
Akt1; Chemosensitivity; Renal cell carcinoma; Sorafenib;
D O I
暂无
中图分类号
学科分类号
摘要
To investigate whether antitumor activity of sorafenib, a potential molecular-targeted agent against RCC is enhanced by silencing Akt1 in a human RCC ACHN model. We established ACHN in which the expression vector containing short hairpin RNA targeting Akt1 was introduced (ACHN/sh-Akt1). Changes in several phenotypes of ACHN/sh-Akt1 following treatment with sorafenib were compared with those of ACHN transfected with control vector alone (ACHN/C) both in vitro and in vivo. When cultured in the standard medium, there was no significant difference in the in vitro growth pattern between ACHN/sh-Akt1 and ACHN/C; however, compared with ACHN/C, ACHN/sh-Akt1 showed a significantly higher sensitivity to sorafenib. Furthermore, treatment with Akt1 inhibitor, A-674563 also resulted in the significantly enhanced sensitivity of parental ACHN to sorafenib. Treatment of ACHN/sh-Akt1 with sorafenib, but not that of ACHN/C, induced marked downregulation of antiapoptotic proteins, including Bcl-2, Bcl-xL, and c-Myc. In vivo administration of sorafenib resulted in the significant growth inhibition of ACHN/sh-Akt1 tumor compared with that of ACHN/C tumor, and despite the lack of Ki-67 labeling index between ACHN/sh-Akt1 and ACHN/C tumors, apoptotic index in ACHN/sh-Akt1 tumor in mice treated with sorafenib was significantly greater than that in ACHN/C tumor. These findings suggest that combined treatment with Akt1 inhibitor and sorafenib could be a promising therapeutic approach for patients with advanced RCC.
引用
收藏
页码:114 / 121
页数:7
相关论文
共 50 条
  • [41] MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib
    Zheng, Bing
    Zhu, Hua
    Gu, Donghua
    Pan, Xiaodong
    Qian, Lin
    Xue, Boxin
    Yang, Dongrong
    Zhou, Jundong
    Shan, Yuxi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 459 (02) : 234 - 239
  • [42] Pharmacological inhibition of β-catenin prevents EndMT in vitro and vascular remodeling in vivo resulting from endothelial Akt1 suppression
    Sabbineni, Harika
    Verma, Arti
    Artham, Sandeep
    Anderson, Daniel
    Amaka, Oge
    Liu, Fang
    Narayanan, Subhadra P.
    Somanath, Payaningal R.
    BIOCHEMICAL PHARMACOLOGY, 2019, 164 : 205 - 215
  • [43] Effect of RNA interference of the expression of HMGA2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells
    Liu, Ying
    Fu, Qi-Zhong
    Pu, Lin
    Song, Ling-Ling
    Wang, Yi-Yun
    Liu, Jing
    Wang, Zhen-Long
    Wang, Zi-Ming
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 5107 - 5112
  • [44] Inhibition of MAPK signaling enchances Sorafenib-mediated cytotoxicity in human cancer cells in vitro and in vivo
    Yu, Chunrong
    Tang, Haikuo
    Friday, Bret
    Miner, Jeffrey
    Chapman, Mark
    Repasky, Elizabeth
    Adjei, Alex
    CANCER RESEARCH, 2009, 69
  • [45] Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro
    Walsh, MD
    Luckie, SM
    Cummings, MC
    Antalis, TM
    McGuckin, MA
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 58 (03) : 255 - 266
  • [46] Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro
    Michael D. Walsh
    Stuart M. Luckie
    Margaret C. Cummings
    Toni M. Antalis
    Michael A. McGuckin
    Breast Cancer Research and Treatment, 1999, 58 (3) : 253 - 264
  • [47] Cyclic and characteristic expression of phosphorylated Akt in human endometrium and decidual cells in vivo and in vitro
    Toyofuku, A
    Hara, T
    Taguchi, T
    Katsura, Y
    Ohama, K
    Kudo, Y
    HUMAN REPRODUCTION, 2006, 21 (05) : 1122 - 1128
  • [49] PI3K/AKT1 Signaling Pathway Mediates Sinomenine-Induced Hepatocellular Carcinoma Cells Apoptosis: An in Vitro and in Vivo Study
    Luo, Yan
    Liu, Liwei
    Zhao, Jihua
    Jiao, Yue
    Zhang, Meiyu
    Xu, Guangli
    Jiang, Yumao
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (05) : 614 - 624
  • [50] The association of vascular cell adhesion molecule-1 expression with the effect of sorafenib in renal cell carcinoma
    Ohno, Y.
    Satake, N.
    Hashimoto, T.
    Gondo, T.
    Nakashima, J.
    Ohori, M.
    Tachibana, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E203 - E203